[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Page S6300]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3075. Mr. COTTON submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   PROHIBITING FEDERAL SPENDING FOR LABORATORIES 
                   LOCATED IN THE PEOPLE'S REPUBLIC OF CHINA.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to health 
     care, which may include prohibiting any Federal funding for 
     laboratories located in the People's Republic of China, by 
     the amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2022 
     through 2026 or the period of the total of fiscal years 2022 
     through 2031.
                                 ______